Select Medical Holdings (SEM) Cash from Financing Activities (2018 - 2026)

Select Medical Holdings has disclosed Cash from Financing Activities across 9 years of filings, most recently posting $18.0 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 63.57% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at -$194.5 million (up 50.74% YoY), while the FY2025 annual figure was -$163.2 million, up 47.57% from the prior year.
• Cash from Financing Activities grew to $18.0 million in Q1 2026, from -$31.0 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for SEM reached as high as $133.0 million in Q1 2024 and fell as low as -$205.5 million in Q2 2024.
• The 5-year median for Cash from Financing Activities is -$46.5 million (2025), against an average of -$48.2 million.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities plunged 400.5% — and 2024, when it jumped 3788.86%.
• A 5-year view of Cash from Financing Activities shows it stood at $34.4 million in 2022, then sank by 400.5% to -$103.3 million in 2023, then tumbled by 77.18% to -$183.0 million in 2024, then surged by 83.08% to -$31.0 million in 2025, then jumped by 157.99% to $18.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $18.0 million, -$31.0 million, and -$135.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.